BACKGROUND AND IMPORTANCE: Fluorescence-guided resection with 5-aminolevulinic acid (5-ALA), which has shown promising results in the resection of malignant gliomas, has been used for meningioma resection in an attempt to more clearly delineate the tumor margin. However, no article has investigated the fluorescence pattern of meningiomas on a histological level. Understanding the microscopic pattern of fluorescence could help assess the precision and utility of using 5-ALA for these tumors. We present the case of a recurrent atypical meningioma operated on with 5-ALA fluorescence-guided resection for delineation of tumor tissue from surrounding uninvolved dura. CLINICAL PRESENTATION: A 53-year-old woman presented with recurrent atypical meningioma of the falx. Prior treatment included surgical resection 6 years earlier with subsequent fractionated radiation therapy and radiosurgery for tumor progression. The patient was given 5-ALA 20 mg/kg body weight dissolved in 100 mL water 3 hours before induction of anesthesia. Intraoperative fluorescence was coregistered with preoperative imaging. Neuropathological analysis of the resected falx with confocal microscopy enabled correlation of fluorescence with the extent of tumor on a histological level. CONCLUSION: Fluorescence guidance allowed clear intraoperative delineation of tumor tissue from adjacent, uninvolved dura. On a microscopic level, there was a very close correlation of fluorescence with tumor, but some tumor cells did not fluoresce.
BACKGROUND AND IMPORTANCE: Fluorescence-guided resection with 5-aminolevulinic acid (5-ALA), which has shown promising results in the resection of malignant gliomas, has been used for meningioma resection in an attempt to more clearly delineate the tumor margin. However, no article has investigated the fluorescence pattern of meningiomas on a histological level. Understanding the microscopic pattern of fluorescence could help assess the precision and utility of using 5-ALA for these tumors. We present the case of a recurrent atypical meningioma operated on with 5-ALA fluorescence-guided resection for delineation of tumor tissue from surrounding uninvolved dura. CLINICAL PRESENTATION: A 53-year-old woman presented with recurrent atypical meningioma of the falx. Prior treatment included surgical resection 6 years earlier with subsequent fractionated radiation therapy and radiosurgery for tumor progression. The patient was given 5-ALA 20 mg/kg body weight dissolved in 100 mL water 3 hours before induction of anesthesia. Intraoperative fluorescence was coregistered with preoperative imaging. Neuropathological analysis of the resected falx with confocal microscopy enabled correlation of fluorescence with the extent of tumor on a histological level. CONCLUSION: Fluorescence guidance allowed clear intraoperative delineation of tumor tissue from adjacent, uninvolved dura. On a microscopic level, there was a very close correlation of fluorescence with tumor, but some tumor cells did not fluoresce.
Authors: Pablo A Valdés; Xiaoyao Fan; Songbai Ji; Brent T Harris; Keith D Paulsen; David W Roberts Journal: Stereotact Funct Neurosurg Date: 2009-11-12 Impact factor: 1.875
Authors: David W Roberts; Pablo A Valdés; Brent T Harris; Kathryn M Fontaine; Alexander Hartov; Xiaoyao Fan; Songbai Ji; S Scott Lollis; Brian W Pogue; Frederic Leblond; Tor D Tosteson; Brian C Wilson; Keith D Paulsen Journal: J Neurosurg Date: 2010-04-09 Impact factor: 5.115
Authors: Dennis Wirth; Kolbein Kolste; Stephen Kanick; David W Roberts; Frédéric Leblond; Keith D Paulsen Journal: Biomed Opt Express Date: 2017-07-14 Impact factor: 3.732
Authors: Pablo A Valdes; Kimon Bekelis; Brent T Harris; Brian C Wilson; Frederic Leblond; Anthony Kim; Nathan E Simmons; Kadir Erkmen; Keith D Paulsen; David W Roberts Journal: Neurosurgery Date: 2014-03 Impact factor: 4.654
Authors: Kimon Bekelis; Pablo A Valdés; Kadir Erkmen; Frederic Leblond; Anthony Kim; Brian C Wilson; Brent T Harris; Keith D Paulsen; David W Roberts Journal: Neurosurg Focus Date: 2011-05 Impact factor: 4.047
Authors: A A Potapov; S A Goryaynov; V A Okhlopkov; L V Shishkina; V B Loschenov; T A Savelieva; D A Golbin; A P Chumakova; M F Goldberg; M D Varyukhina; A Spallone Journal: Neurosurg Rev Date: 2016-02-18 Impact factor: 3.042
Authors: Marcel A Kamp; Zarela Krause Molle; Christopher Munoz-Bendix; Marion Rapp; Michael Sabel; Hans-Jakob Steiger; Jan F Cornelius Journal: Neurosurg Rev Date: 2016-05-25 Impact factor: 3.042
Authors: Arash Motekallemi; Hanne-Rinck Jeltema; Jan D M Metzemaekers; Gooitzen M van Dam; Lucy M A Crane; Rob J M Groen Journal: Neurosurg Rev Date: 2015-03-05 Impact factor: 3.042